当資料は、3M社(本社:米国ミネソタ州、NYSE:MMM)が2024年1月15日(現地時間)に発表した報道資料を抄訳したものです。
コンバット・アーム・イヤープラグの和解合意は2023年8月に発表されて以来、請求人や幅広い軍関係者から強力かつ広範なサポートを受けています。このサポートのおかげで、当事者と裁判所は、和解の完全実施に向けて合意で定められた次のマイルストーンに到達できました。
具体的には、和解合意前に裁判の準備を進めていた「ウェーブ」の原告団が、和解に参加し、請求を放棄することに同意しました。3Mは、この強力なサポートと残りのウェーブの請求人の100%の参加を認め、既存の和解合意の時期を修正しました。同社は、これらの請求の解決に向けたコミットメントに沿って、これらの案件に対する支払い(2億5,310万ドル)を2024年1月31日までに前倒しする予定です。
Aearoと3Mは、和解合意の完全実施に向けてすべての当事者および裁判所と引き続き協力し、さらなるマイルストーンが達成され次第、最新情報を提供する予定です。
一定の条件が満たされた場合に予想される支払いスケジュールなど、本合意の詳細については、3Mが証券取引委員会に提出した書類をご覧ください。
詳しくは3m-earplugsettlement.comをご覧ください。
Forward-Looking Statements
This news release contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate, "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation, recession, military conflicts, natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) risks related to certain fluorochemicals, including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's plans to exit PFAS manufacturing and discontinue use of PFAS across its product portfolio; (4) risks related to the proposed class-action settlement to resolve claims by public water systems in the United States regarding PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2022 and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the proposed spin-off of the Company's Health Care business; and (16) matters relating to Combat Arms Earplugs ("CAE"), including those relating to the August 2023 settlement that is intended to resolve all litigation and alleged claims involving the CAE sold or manufactured by the Company's subsidiary Aearo Technologies and certain of its affiliates ("Aearo Entities") and/or the Company. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.
【3Mについて】
3M(本社:米国ミネソタ州)は、サイエンス(科学)が明るい未来を創造すると信じています。人びと、アイデア、サイエンスの力を解き放つことによりさらなる可能性を模索し、世界中の社員がお客様、地域社会、そして地球の課題を解決するために取り組んでいます。人びとの暮らしを豊かにし、「これから」を創り出すための3Mの活動は3M.com/newsをご覧ください。3Mジャパングループについてはnews.3mcompany.jp/news-centerをご覧ください。
3Mは3M社の商標です。
ニュースリリースに掲載している内容は発表時点の情報です。
最新の情報とは異なる場合がございますので、あらかじめご了承ください。